1375301-92-0 Usage
General Description
6-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)quinazoline is a chemical compound with the molecular formula C17H19BNO2. It is a quinazoline derivative that contains a boron containing heterocycle. 6-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)quinazoline has promising applications in the field of organic synthesis and medicinal chemistry. It is used as a reagent in various chemical reactions and synthetic processes, and it also exhibits potential pharmacological activities. 6-(4,4,5,5-TetraMethyl-1,3,2-dioxaborolan-2-yl)quinazoline is of interest to researchers and scientists in the development of new drugs and materials due to its unique chemical properties and potential biological activities.
Check Digit Verification of cas no
The CAS Registry Mumber 1375301-92-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,5,3,0 and 1 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1375301-92:
(9*1)+(8*3)+(7*7)+(6*5)+(5*3)+(4*0)+(3*1)+(2*9)+(1*2)=150
150 % 10 = 0
So 1375301-92-0 is a valid CAS Registry Number.
1375301-92-0Relevant articles and documents
FUSED RING DERIVATIVE AS A2A RECEPTOR INHIBITOR
-
Paragraph 0112-0114, (2020/08/09)
Disclosed are a compound represented by formula (I) or a pharmaceutically acceptable salt thereof, and an application of the compound or slat in preparation of drugs for treating diseases related to an A2A receptor.
Heterocyclic compound with Wnt signal path inhibitory activity and application thereof
-
Paragraph 0101; 0102; 0103, (2016/10/08)
The invention provides a heterocyclic compound with Wnt signal path inhibitory activity. The heterocyclic compound and chemically acceptable salt, isotope, isomer and a crystal structure thereof are provided with a structure shown as the general formula I (see the formula in the description). The invention further provides application of the heterocyclic compound with the Wnt signal path inhibitory activity. The heterocyclic compound with the Wnt signal path inhibitory activity serves as effective antagonist of a Wnt signal path, and can be used for treating or preventing diseases caused by abnormity of the Wnt signal path.
